This is a preview of subscription content, log in via an institution to check access.
Reference
Discovery Laboratories Inc. New Pharmacoeconomic Analysis Shows Lower Rate of Reintubation Observed With SURFAXIN Treatment May Reduce Hospital Costs Associated with Bronchopulmonary Dysplasia. Media Release : 4 Dec 2012. Available from: URL: http://www.discoverylabs.com
Rights and permissions
About this article
Cite this article
Select sinapultide and save. PharmacoEconomics & Outcomes News 669, 7 (2013). https://doi.org/10.1007/s40274-013-0057-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0057-7